Alferon natural alpha interferons data

Two Phase II trials were presented at the Chicago meeting of the American Association for the Study of Liver Diseases, with good tolerability found in both treatment-naive patients and patients who had previously received recombinant interferon.

The trials were open label and used several subcutaneous doses. ...